Aplenzin
bupropion hydrobromide
- Strength
- 174 mg/1
- Form
- Tablet, Extended Release
- Class
- Aminoketone
Bausch Health US, LLC
Listed by Oceanside Pharmaceuticals
| Dosage form | Tablet, Extended Release |
|---|---|
| Route | Oral |
| Drug class | Aminoketone |
| Approval route | Authorised generic |
| NDC code | 68682-582 |
| FDA application | NDA022108 |
| RxNorm concept | 993550 |
| Package sizes listed | 1 |
| Marketed since | June 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
bupropion hydrobromide
Bausch Health US, LLC
bupropion hydrobromide
Bausch Health US, LLC
bupropion hydrobromide
Bausch Health US, LLC
bupropion hydrochloride
Northwind Health Company, LLC
Zydus Pharmaceuticals USA Inc.
Zydus Pharmaceuticals USA Inc.
Zydus Lifesciences Limited
Proficient Rx LP
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.